Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.710
+0.040 (1.09%)
At close: Nov 13, 2026, 4:00 PM EST
3.710
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:15 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $240.27 million as of November 13, 2026. It is the 19,461st most valuable company in the world and the 3,382nd biggest in the United States. Its market cap has decreased by 43.79% in one year.
Market Cap
240.27M
Enterprise Value
77.69M
1-Year Change
-43.79%
Global Rank
Country Rank
#3,382 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $240.27M, a decrease of -34.32%. That is a compound annual growth rate of -7.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 240.27M | -43.45% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 268.34M |
| vTv Therapeutics | 266.76M |
| Inovio Pharmaceuticals | 264.97M |
| Protalix BioTherapeutics | 263.92M |
| Camp4 Therapeutics | 263.57M |
| Clinuvel Pharmaceuticals | 260.90M |
| Bicycle Therapeutics | 258.65M |
| Lexeo Therapeutics | 251.87M |